Raymond James Financial’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.9M Sell
205,020
-4,107
-2% -$1.74M 0.02% 675
2026
Q1
$99M Sell
209,127
-14,282
-6% -$7.19M 0.03% 516
2025
Q4
$104M Sell
223,409
-10,166
-4% -$4.72M 0.03% 492
2025
Q3
$99.5M Sell
233,575
-5,047
-2% -$1.96M 0.03% 508
2025
Q2
$91.4M Buy
238,622
+13,258
+6% +$4.78M 0.03% 511
2025
Q1
$77.9M Sell
225,364
-21,582
-9% -$6.94M 0.03% 518
2024
Q4
$74.1M Buy
+246,946
New +$86.3M 0.03% 533

Other funds holding HCA

Raymond James Financial's HCA Position: Q2 2026 in Review

Raymond James Financial reduced its HCA Healthcare (HCA) stake by 2% in Q2 2026, selling an estimated $1.74M and leaving 205,020 shares worth $79.9M. The position accounts for 0.02% of the portfolio, ranked #675.

Raymond James Financial first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $104M in Q4 2025. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Raymond James Financial held 205,020 shares of HCA Healthcare worth $79.9M as of Q2 2026.
  • Raymond James Financial sold 4,107 HCA Healthcare shares in Q2 2026, an estimated $1.74M.
  • HCA Healthcare made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #675 holding.
  • Raymond James Financial first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's HCA Healthcare position peaked at $104M in Q4 2025.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.